MAPT and Alzheimer disease: We thus obtained postmortem EC samples with either a Braak II histopathological classification that we will refer to as Alzheimer’s disease neuropathology (ADN1-ADN5) or with no tau pathology (C1-C5) (Supplementary Table 1).